81. Congenital adrenal hyperplasia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 87 / Drugs : 87 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68
| Previous names | - | ||
|---|---|---|---|
| Other names | CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency; | ||
| Disease group | Endocrine diseases | ||
| Related info (in Japanese) | - | ||
| Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) (1), (2), (3), (4), (5), (6) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 5-23-47. Aldosterone synthase deficiency | ||
| 5-25-50. Congenital lipoid adrenal hyperplasia | |||
| 5-25-51. 3 beta-hydroxysteroid dehydrogenase deficiency | |||
| 5-25-52. 11 beta-hydroxylase deficiency | |||
| 5-25-53. 17 alpha-hydroxylase deficiency | |||
| 5-25-55. P450 oxidoreductase deficiency | |||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 81-1. | Congenital Lipoid Adrenal Hyperplasia; | 5-25-50. Congenital lipoid adrenal hyperplasia | |
| 81-2. | 3β-Hydroxysteroid Dehydrogenase Deficiency; | 5-25-51. 3 beta-hydroxysteroid dehydrogenase deficiency | |
| 81-3. | 21-Hydroxylase deficiency;21-OHD; | 5-25-54. 21-hydroxylase deficiency | |
| 81-4. | 11β-Hydroxylase deficiency; | 5-25-52. 11 beta-hydroxylase deficiency | |
| 81-5. | 17α-Hydroxylase deficiency; | 5-25-53. 17 alpha-hydroxylase deficiency | |
| 81-6. | P450 oxidoreductase deficiency; | 5-25-55. P450 oxidoreductase deficiency | |
| 81-7. | Aldosterone synthase deficiency; | 5-23-47. Aldosterone synthase deficiency | |